Authorization

Aeglea BioTherapeutics to Present at BIO Digital 2020

AUSTIN, Texas, June 01, 2020 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare and other high-burden diseases, today announced it will provide a corporate overview at BIO Digital being held virtually June 8-12, 2020.
Presentation DetailsDate:A June 8-12, 2020
Presenter:A Anthony G. Quinn, M.B. Ch.B., Ph.D., Aegleaa??s president and chief executive officer
Location:A https://www.bio.org/events/bio-digitalThe presentation will be available for download on the Presentations & Events section of the Companya??s website and also will be available on-demand to registered participants of BIO Digital at https://www.bio.org/events/bio-digital/sessions/620997.About Aeglea BioTherapeutics
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Июль 2020    »
ПнВтСрЧтПтСбВс
 12345
6789101112
13141516171819
20212223242526
2728293031